SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Trumps statement that the U.S. would not strike Iran has fueled hopes of a relief bounce in SPY, though traders remain divided over whether the pause signals de-escalation or merely delays further conflict. Persistent worries about oil-driven inflation and possible renewed hostilities, alongside the Fed decision and major tech earnings, are keeping volatility and downside risks in focus.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

The FDA-cleared expansion of Alpha Taus recurrent glioblastoma REGAIN trial and upcoming clinical data are the dominant focus, with traders citing the early results as encouraging while acknowledging the evidence comes from a small patient group. The Samsung Medical Center MOU for exploring a pancreatic cancer study is also drawing attention as a secondary pipeline development.

ProShares Trust II - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

BOIL is drawing attention amid volatile natural-gas futures trading, with traders debating weather forecasts, storage injections, production and pipeline disruptions as drivers of sharp swings. Bears point to mild-weather expectations, ample supply and the ETFs leverage and futures-roll decay, while bulls are watching for winter demand or tighter storage to support a rebound.

ProShares Trust II - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is drawing attention as traders position for weaker natural-gas prices, citing ample storage, strong production, and expectations for mild weather to restrain demand. Others warn that heat, tighter storage reports, or LNG disruptions could trigger sharp counter-rallies, adding to volatility in the leveraged inverse fund.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyvernas positive registrational-trial results for miv-cel in stiff person syndrome, alongside encouraging longer-term data in generalized myasthenia gravis, are driving attention. Traders are impressed by the durability and breadth of benefit, but the stocks sharp swings have prompted debate over serious adverse events, profit-taking, and possible dilution.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Robloxs upcoming quarterly report is the main focus, with traders weighing a lowered bookings outlook and soft spending against resilient user engagement and interest in viral games. Some see reset expectations as a chance for a better reaction, while others worry the company could again fall short of the markets bar after prior post-earnings selloffs.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers climb back toward $30 and a new 52-week high is the dominant conversation, with traders celebrating a long-awaited rebound and pointing to pipeline progress and defensive-sector interest. Others question whether the move can hold, citing resistance near $30 and lingering concerns about patent expirations and the need for stronger growth catalysts.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

Occidentals recent strength is drawing attention as traders watch a technical breakout and position ahead of the upcoming earnings report, with firm crude prices and broader energy-sector gains providing context. The mood is largely bullish on momentum, though some traders question whether the shares are keeping pace with oil and note their sensitivity to volatile geopolitical headlines.

iShares Inc. - iShares MSCI Brazil ETF

iShares MSCI Brazil ETF

Brazils presidential runoff is driving attention, with traders attributing EWZs rally and heavy call activity to expectations of a Flvio Bolsonaro win, though the result remains uncertain. The bullish positioning is tempered by put buying and concern that the election move may already be priced in, leaving traders focused on event volatility.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is drawing attention amid a volatile tech-led selloff and rebound, with traders debating whether concerns about AI spending and financing, alongside rising oil and Iran-related uncertainty, will keep pressure on technology stocks. The community is split between buying the dip and expecting another leg lower.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Halberd Corp. is a development stage company, which engages in the research and development of antibodies and devices for the prevention, detection, and treatment of neurodegenerative diseases. It offers patented extracorporeal treatment that is applicable to various blood-borne and neurologic diseases such as PTSD/ CTE (Post Traumatic Stress Disorder/Chronic Traumatic Encephalopathy), Alzheimer's Disease, and Parkinson's Disease. The company was founded by Mark Sven Lundquist and John Christopher Maddox on January 26, 2009 and is headquartered in Jackson Center, PA.

Halberd Corp

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$0.0016
Prev Close	$0.0016
Open	$0.0018
Dividend Yield	0.00%
50-Day Moving Average	$0.0011
Beta	0.71
Avg. Volume	630,080.00
PE Ratio	0.00

52-Week High	$0.0021
52-Week Low	$0.0006
Market Capitalization	$851,193.00
EPS (Annual)	$0.00
Price to Book	-1.33
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

HALB Fundamentals